Related Experiment Video
Updated: Apr 21, 2026
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
γδ T cells as a potential tool in colon cancer immunotherapy
Thiranut Ramutton1, Simona Buccheri, Francesco Dieli
1Department of Biopathology & Biomedical Methodologies, University of Palermo, Palermo, Italy.
Abstract:
γδ T cells are capable of recognizing tumor cells and exert potent cellular cytotoxicity against a large range of tumors, including colon cancer. However, tumors utilize numerous strategies to escape recognition or killing by patrolling γδ T cells, such a downregulation of NKG2D ligands, MICA/B and ULBPs. Therefore, the combined upregulation of T-cell receptorand NKG2D ligands on tumor cells and induction of NKG2D expression on γδ T cells may greatly enhance tumor killing and unlock the functions of γδ T cells. Here, we briefly review current data on the mechanisms of γδ T-cell recognition and killing of colon cancer cells and propose that γδ T cells may represent a promising target for the design of novel and highly innovative immunotherapy in patients with colon cancer.
Insights
Gamma delta (γδ) T cells show promise for colon cancer immunotherapy by recognizing and killing tumor cells. Enhancing their function could overcome tumor evasion strategies for better cancer treatment.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Gamma delta (γδ) T cells possess inherent cytotoxicity against various tumors, including colon cancer.
- Tumors employ evasion mechanisms, such as downregulating NKG2D ligands (MICA/B, ULBPs), to escape γδ T cell-mediated killing.
- Targeting γδ T cells offers a potential avenue for novel colon cancer immunotherapies.
Purpose of the Study:
- To review current data on γδ T cell recognition and killing of colon cancer cells.
- To explore strategies for enhancing γδ T cell anti-tumor activity.
- To propose γδ T cells as a promising target for colon cancer immunotherapy.
Main Methods:
- Review of existing literature on γδ T cell mechanisms in colon cancer.
- Analysis of tumor evasion strategies targeting γδ T cells.
- Exploration of combined therapeutic approaches to enhance γδ T cell function.
Main Results:
- γδ T cells are capable of recognizing and exerting cytotoxicity against colon cancer cells.
- Downregulation of NKG2D ligands is a key tumor escape mechanism.
- Combined upregulation of T-cell receptor and NKG2D ligands, alongside induced NKG2D expression on γδ T cells, may enhance tumor killing.
Conclusions:
- γδ T cells represent a promising target for innovative colon cancer immunotherapy.
- Overcoming tumor evasion strategies is crucial for unlocking γδ T cell anti-tumor functions.
- Further research into modulating γδ T cell activity could lead to novel therapeutic designs.
